|Total number of outstanding shares forming the capital 4,959,935 ordinary shares under ISIN FR0000054694 1,450,996 preferred shares under ISIN FR0010833251||6,410,931|
|Total number of outstanding shares forming the capital
with voting rights 4,959,935 ordinary shares under ISIN FR0000054694 0 shares from stock-options under ISIN FR0000054694
|Number of shares with double voting rights||86,947|
|Total number of gross voting rights||5,046,882|
|Number of shares without voting rights 7,000 registered shares 2,632 bearer shares in the frame of the liquidity contract|
|Total number of exercisable voting rights*||5,037,250|
*Real number of voting rights = total number of voting rights - number of shares without voting rights.
If you would like to receive financial information about Naturex by e-mail, go to : www.naturex.fr
NATUREX has been listed on segment B of NYSE Euronext Paris since October 1996
Number of shares in the capital : 6,410,9314,959,935 ordinary shares (ISIN FR0000054694) 1,450,996 preferred shares(ISIN FR0000010833251)
Naturex is part of the following indexes :
SBF250, CAC All Shares, CAC Mid&Small 190, CAC Small 90, Gaïa Index
Naturex is eligible for the "long-only" DSS on NYSE Euronext Paris.
MNEMO: NRX - Reuters: NATU.PA - Bloomberg: NRX:FP
Naturex is the global leader in speciality plant-based natural ingredients.
The Group, organised around three strategic markets - Food & Beverage, Nutrition & Health and Personal Care - produces and markets specialty plant-based natural ingredients for the food, nutraceutical, pharmaceutical and cosmetic industries.
Naturex's head office is based in Avignon. The company employs more than 950 people and has high-performance industrial resources through its 11 industrial sites in Europe (France, Italy, Spain, the United Kingdom and Switzerland), as well as in Morocco, the United States, Brazil and Australia. It also benefits from sales presence around the world through a dedicated network in 16 countries (France, Italy, Spain, the United Kingdom, Belgium, Germany, Switzerland, Russia, U.A.E., Thailand, Singapore, Japan, China, Australia, the United States and Brazil).
Naturex's sound performance is linked to the fast-growing demand for natural products and its capacity to provide manufacturers with the personalised means to meet the requirements of their end consumers. The Group's strength lies in its ability to position itself on specific products which constitute niche markets, thanks to sustained Research & Development.
Chairman and CEO
Tel.: +33 (0)4 90 23 96 89
Vice-Chairman and CFO
Tel.: +33 (0)4 90 23 96 89
Tel.: +33 (0)4 90 23 78 28
|Contacts Actus Finance|
|Anne Catherine Bonjour
Actus Press Relations
Tel.: +33 (0)1 53 67 36 93
Tel.: +33 (0)1 77 35 04 36
Information relative au nombre total de droits de vote et d'actions composant le capital :
- Communiqué intégral et original au format PDF :
http://www.actusnews.com/documents_communiques/ACTUS-0-22891-cp-naturex-en-03032011.pdf © Copyright Actusnews Wire
Recevez gratuitement par email les prochains communiqués de la société en vous inscrivant sur www.actusnews.com
Receive by email the next press releases of the company by registering on www.actusnews.com, it's free
|NATUREX||Euronext Paris||85.00 (c)||1.19%||1 232|